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Upon coexpression with Erwinia geranylgeranyldiphosphate (GGDP) synthase in Escherichia coli, C30 ca-
rotenoid synthase CrtM from Staphylococcus aureus produces novel carotenoids with the asymmetrical C35
backbone. The products of condensation of farnesyldiphosphate and GDP, C35 structures comprise 40 to 60%
of total carotenoid accumulated. Carotene desaturases and carotene cyclases from C40 or C30 pathways
accepted and converted the C35 substrate, thus creating a C35 carotenoid biosynthetic pathway in E. coli.
Directed evolution to modulate desaturase step number, together with combinatorial expression of the desatu-
rase variants with lycopene cyclases, allowed us to produce at least 10 compounds not previously described.
This result highlights the plastic and expansible nature of carotenoid pathways and illustrates how combina-
torial biosynthesis coupled with directed evolution can rapidly access diverse chemical structures.
Impressively diverse and rich in biological activity, natural
secondary metabolites comprise but a fraction of the chemicals
that could be made by biological systems. Some new metabo-
lites can be accessed by coexpressing biosynthetic genes from
different sources in a recombinant host (combinatorial biosyn-
thesis [22–25, 28]). Alternatively, the new pathways can also be
evolved, or bred, in the laboratory; here, new biosynthetic
functions are created within the context of a pathway by ran-
dom mutagenesis and recombination of biosynthetic genes
coupled with screening for the products of newly emerging
branches (26, 27). For this strategy to be useful, it is important
to understand how natural secondary metabolic pathways are
structured, how they can rapidly explore new chemical struc-
tures, and, most importantly, how we can use evolutionary
algorithms to accelerate this search.
Secondary metabolic pathways appear to be able to explore
new chemical structures at minimal cost (7). Key to promoting
facile exploration is the extensive use of promiscuous enzymes
that can accept a variety of substrates. Thus, once a new com-
pound is produced, as a result of either enzyme recruitment or
mutation in an existing enzyme, it is further metabolized by
downstream modifying enzymes, thereby allowing a series of
novel compounds to emerge. Such “hidden” branches have
been found in several natural pathways (5, 9, 10, 15). In breed-
ing pathways in the laboratory, we can exploit this feature to
generate new molecular diversity.
Carotenoids are natural pigments that play various biologi-
cal roles (3, 14, 18, 20). At least 700 carotenoids have been
characterized (12) from the two known carotenoid biosynthetic
pathways. Most widely distributed is the C40 pathway, which is
shared by thousands of plant and microbial species. In this
pathway, two molecules of geranylgeranyldiphosphate (GGDP)
(C20PP) are condensed to form phytoene (Fig. 1, compound
3). The second, C30 pathway is known in only a few bacterial
species, such as those of Staphylococcus and Heliobacterium
(29, 31, 32). Here, two molecules of farnesyldiphosphate
(FDP) (C15PP) undergo condensation to form 4,4-diapophy-
toene (dehydrosqualene) (Fig. 1, compound 1). Homo (C40)-
and apo (C40)-carotenoids are also known; they derive from
C40 carotenoid precursors (1, 2, 16, 17). Most natural carot-
enoid diversity arises from differences in types and levels of
desaturation and other modifications of the C40 backbone.
Why nature has chosen these two pathways and not others is
not known. We are testing whether novel pathways for non-C30
and non-C40 carotenoids can be created and how easily such
new pathways generate molecular diversity. Here we report the
construction of a C35 carotenoid pathway in Escherichia coli.
This pathway emerged when the C30 carotene synthase CrtM
from Staphylococcus aureus was supplied with the natural sub-
strate of the C40 synthase, GGDP. Other carotenoid-synthe-
sizing enzymes, specifically, carotene cyclases and desaturases
from C40 and C30 pathways, were found to be functional on the
C35 backbone, and thus a C35 carotenoid pathway was quickly
established. Directed evolution of a carotene desaturase
yielded variants with altered step number and increased the
variety of C35 carotenoids that could be produced by the new
pathway.
MATERIALS AND METHODS
Materials. crtE (GGDP synthase), crtB (phytoene synthase), crtI (phytoene
desaturase), and crtY (-end lycopene cyclase) from Erwinia uredovora were
obtained by genomic PCR as described previously (27). crtM (diapophytoene
synthase) and crtN (diapophytoene desaturase) were PCR cloned from genomic
DNA of S. aureus (ATCC 35556). Lettuce dy4 (ε-end lycopene cyclase) (6) was
kindly provided by Francis X. Cunningham, Jr. (University of Maryland). Am-
pliTaq polymerase (Perkin-Elmer, Boston, Mass.) was used for mutagenic PCR,
while Vent polymerase (New England Biolabs, Beverly, Mass.) was used for
cloning PCR. All chemicals and reagents were of the highest available grade.
Plasmid construction. To express carotenoid biosynthetic enzymes, we used
the lac promoter system devoid of operator sequence, as described previously
(27). Instead of providing promoters for each pathway component, however, we
placed multiple genes under the control of a single lac promoter. Each open
reading frame, following a Shine-Dalgarno sequence (in bold) and a spacer
(AGGAGGATTACAAA), was PCR cloned into the plasmid to form artificial
operons. Genes in plasmids and operons are always listed in transcriptional
order. Carotene synthases (crtM and crtB) are flanked by XbaI-XboI sites, car-
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otene desaturases (crtN and crtI) are flanked by XhoI-EcoRI sites, and crtE is
flanked by EcoRI-NcoI sites.
For production of cyclic carotenoids, we used a two-plasmid expression system.
Each operon that produces acyclic carotenoids was transferred from the pUC
vector into pACYC184. To do this, we amplified an entire operon by using a pair
of primers (5-AGCTGGGTCGACAGGTTTCCCGACTGGAAAGCG-3) and
(5-ACCATAGTCGACGTGAAATACCGCACAGATGCG-3) targeted out-
side the promoter and multicloning sites (the SalI sitea are underlined). The
PCR product was then digested and cloned into the SalI site of pACYC184,
resulting in pAC-crtM-crtN-crtE. In a similar way, pAC-crtM-crtI-crtE and others
were constructed. Carotene cyclase genes (Erwinia crtY and lettuce dy4) were
subcloned into the EcoRI-NcoI sites of pUC, resulting in pUC-crtY and pUC-
dy4.
Pigment analysis. Among the strains we tested as expression hosts, XL1-Blue
showed the best results in terms of stability and intensity of the color developed
by colonies on agar plates, although HB101 and BL21 were better for carotenoid
production in liquid culture. Because all of the genes assembled in each plasmid
are grouped under a single lac promoter without an operator, our expression
system was constitutive and insensitive to IPTG (isopropyl--D-thiogalactopyr-
anoside) induction.
Pigment analysis was conducted as described previously (33). Briefly, wet cells
harvested from 40 ml of Terrific Broth (TB) culture were extracted with 20 ml of
acetone. To this, 10 ml of hexane and 10 ml of aqueous NaCl (10%, wt/vol) were
added, and the mixture was shaken vigorously to remove oily lipids. The upper
phase containing the carotenoids was dried with anhydrous MgSO4 and concen-
trated in a rotary evaporator. An aliquot of the extract was passed through a
Spherisorb ODS2 column (250 by 4.6 mm; particle diameter, 5 m; Waters,
Milford, Mass.) and eluted with an acetonitrile-isopropanol mixture (85:15 or
80:20, vol/vol) at a flow rate of 1 ml/min, using an Alliance high-pressure liquid
chromatography (HPLC) system (Waters) equipped with a photodiode array
detector. Mass spectra were obtained by using a series 1100 LC/MSD (Hewlett-
Packard/Agilent, Palo Alto, Calif.) coupled with an atmospheric pressure chem-
ical ionization interface.
PCR mutagenesis and color screening of carotenoid desaturases. A pair of
primers, 5-GAACGTGTTTTTGTGGATAAGAGG-3 and 5-GATGAACGT
GTTTTTTTGCGCAGACCG-3, flanking crtN were designed to amplify the
1.6-kb gene by PCR under mutagenic conditions; the reaction mixtures con-
tained 5 U of AmpliTaq (100-l total volume), 20 ng of template (pUC-crtM-
crtN-crtE), 50 pmol of each primer, a 0.2 mM concentration of each deoxynucleo-
side triphosphate, and 5.5 mM MgCl2. Three mutagenic libraries were made by
using three different MnCl2 concentrations: 0.1, 0.05, and 0.02 mM. The tem-
perature cycling scheme was 95°C for 4 min; followed by 30 cycles of 95°C for
30 s, 52°C for 30 s, and 72°C for 2 min; followed by a final stage of 72°C for 10
min. PCR yields for the 1.6-kb amplified fragment were 5 g, corresponding to
an amplification factor of ca. 500, or nine effective cycles. The PCR product from
each library was purified by using a Zymoclean gel purification kit (Zymo Re-
search, Orange, Calif.) followed by digestion with XhoI and EcoRI. The frag-
ments were ligated into the desaturase site of vector pUC-crtM-crtN-crtE, result-
ing in pUC-crtM-[crtN]-crtE libraries (square brackets indicate the randomly
mutagenized gene). PCR mutagenesis of crtI on plasmid pUC-crtM-crtI-crtE was
performed under the same conditions used for mutagenesis of crtN. The PCR
products were purified, digested, and ligated as described above into the desatu-
rase site of pUC-crtM-crtI-crtE, resulting in four pUC-crtM-[crtI]-crtE libraries.
The ligation mixtures were transformed into E. coli XL1-Blue cells. Colonies
were grown on Luria-Bertani agar–carbenicillin plates at 37°C for 16 h. Colonies
were lifted onto white nitrocellulose membranes (Pall, Port Washington, N.Y.)
and visually screened for color variants after an additional 12 to 24 h at room
temperature. Selected colonies were picked and cultured overnight in 96-deep-
well plates, with each well containing 0.5 ml of liquid Luria-Bertani medium
supplemented with carbenicillin (50 g/ml). For the selected variants, the entire
operons containing the promoter region were subcloned into the pACYC vector
(see above).
FIG. 1. Three pathways for carotenoid biosynthesis. In addition to natural C30 and C40 carotenoid pathways, a C35 carotenoid pathway has been
constructed in E. coli. The number for each carotenoid corresponds to those in the other figures.
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RESULTS
C30 carotenoid enzymes shift their pigment production in
the presence of GGDP. For the production of C30 carotenoids,
we subcloned crtM (dehydrosqualene synthase) and crtN (de-
hydrosqualene desaturase), both from S. aureus (35), into a
pUC19 derivative (27) to generate plasmid pUC-crtM-crtN. E.
coli XL1 transformed with pUC-crtM-crtN shows a typical yel-
low color due to C30 carotenoid production. In contrast, when
XL1 cells were transformed with pUC-crtM-crtN-crtE, where
crtE (GGDP synthase) from E. uredovora was additionally ex-
pressed, they exhibited an intense red color (Fig. 2A). The
spectrum of the acetone extract has a shoulder at 525 nm,
indicating the presence of a polyene containing 13 conjugated
double bonds. Because the C30 backbone accommodates only
11 conjugated double bonds, it appeared that the cells were
producing aC30 carotenoid. CrtN was previously shown to be
functional to some extent on C40 carotenoids, but both in vitro
and in vivo experiments showed that it is not more than a
three-step desaturase in a C40 pathway (21, 33). Indeed, XL1
cells harboring pUC-crtB-crtN-crtE (with the C40 synthase) are
yellow (Fig. 2A) and solely accumulate neurosporene. There-
fore, the source of the red hue of XL1 cells transformed with
pUC-crtM-crtN-crtE was believed to be a novel carotenoid with
a non-C30, non-C40 backbone.
CrtM produces 4-diapophytoene in the presence of GGDP.
E. coli cells harboring pUC-crtE-crtB exclusively produced phy-
toene (C40) (compound 3; M
 at m/e  544.5) (Fig. 3C), while
E. coli carrying pUC-crtB accumulated undetectable amounts
of carotenoids (data not shown). Thus, crtB appears to be a
specific C40 synthase. E. coli cells transformed with pUC-crtM
produced only diapophytoene (C30) (compound 1; m/e 
408.5) (Fig. 3B). When E. coli was transformed with pUC-
crtM-crtE, however, three carotenoids accumulated: in addi-
tion to phytoene (C40) and 4,4-diapophytoene (C30), a novel
phytoene-type carotenoid, 4-apophytoene (C35) appeared
(compound 2; m/e  476.5) (Fig. 3A). We believe that this
carotenoid is synthesized via heterocondensation of FDP (C15)
and GGDP (C20) (C15  C20  C35 [Fig. 1]) catalyzed by
CrtM.
Among the E. coli strains tested, HB101 was the best pro-
ducer of compound 2, both in its production level (220 to 350
nmol [100 to 170 g] of C35 carotenoid/g [dry mass] of cells)
and in its proportion to the total carotenoids (55%). BL21
and BL21Gold also showed similarly good C35 production,
while XL1, DH5	, XL10Gold, and TOP10 cells accumulated
compound 2 at a slightly lower level (35 to 45 g/g of cell; ca.
40% of total carotenoids). For those strains, no significant
effects on cell growth were observed. On the other hand,
JM109, JM101, and BL21(DE3) turned out to be very poor
and unstable producers of C35 carotenoids. This might partially
explain why others who expressed the same combination of
genes in JM101 (21) did not describe this compound. On the
other hand, our production of compound 2 was reproducible
and insensitive to changes in other parameters. Replacement
of the pUC-derived expression vector (with a ColE1 origin and
ampicillin marker) with the pACYC184 derivative (with a
p15A origin and chloramphenicol marker) gave virtually no
change in the amount or composition of carotenoids produced.
Likewise, carotenoid production by E. coli carrying pACYC-
crtM-crtE and pUC-crtN or E. coli harboring pACYC-crtN-crtE
and pUC-crtM was virtually the same (data not shown). This
insensitivity to the expression system greatly facilitated the
addition of carotenoid-modifying enzymes such as carotene
cyclases. E. coli transformed with pUC-crtM produced only
diapophytoene (C30) (Fig. 3B, compound 1).
Upon coexpression of CrtE (GGDP synthase), production
FIG. 2. (A) Cell pellet of XL1 cells harboring pUC-crtM-crtN,
pUC-crtM-crtN-crtE, and pUC-crtB-crtN-crtE. (B) Typical view of agar
plates of XL1 cells transformed with the pUC-crtM-[crtN]-crtE library.
FIG. 3. HPLC analysis of carotenoid extract from HB101 cells car-
rying plasmids pUC-crtM-crtE (A), pUC-crtM (B), and pUC-crtE-crtB
(C). Individual compounds are as follows: peak 1, 4,4-diapophytoene;
peak 2, 4-apophytoene; peak 3, phytoene. Elution conditions: ODS-2
column; 1 ml/min; acetonitrile–2-propanol (80:20). The detection
wavelength was 286 nm.
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of 4,4-diapophytoene (the natural product) by CrtM dropped
dramatically, to ca. 1/50 to 1/75 of that in its absence (ca. 1
mg/g of cell). This indicates that CrtE readily consumes FDP
for GGDP production and that FDP for C30 synthesis is se-
verely limited. Based on this, it is assumed that C35 production
is the result of uptake of GGDP by CrtM when FDP is de-
pleted.
Desaturation in the C35 pathway. It is known that diapophy-
toene (C30) desaturase (staphylococcal CrtN) is able to convert
phytoene (C40) to some extent. Likewise, phytoene desaturases
can accept 4,4-diapophytoene (21, 33). Thus, it was not sur-
prising that the S. aureus CrtN (from a C30 pathway) and E.
uredovora CrtI (from a C40 pathway) were functional in the C35
pathway. Figure 4B and C show the HPLC analysis of the
extracted pigments from XL1 transformed with pUC-crtM-
crtN-crtE or pUC-crtM-crtI-crtE, respectively. Both cells accu-
mulated two carotenoids, compounds 6 and 7, that were not
found in cells without CrtE (Fig. 4A). Elution profiles, UV-
visible spectra, and mass spectra (M at m/e 466.5 and 468.5,
respectively) confirmed that peak 6 is the fully conjugated C35
carotenoid, 4-apo-3,4-didehydrolycopene, while peak 7 cor-
responds to a C35 carotenoid with 11 conjugated double bonds.
Because C35 carotenoids are asymmetric, there are two possi-
ble such C35 structures, 4-apolycopene and 4-apo-3,4-didehy-
dro-7,8-dihydrolycopene (Fig. 1). At present, it is not known
which is the actual structure corresponding to peak 7.
The apparent step number of CrtI was slightly greater than
that of CrtN in the C35 pathway, and XL1 cells carrying pUC-
crtM-crtI-crtE accumulated compound 6 as the main product.
The apparent in vivo activity of these desaturases in the C35
pathway was high enough so that unconverted substrate (com-
pound 2) and products with lower desaturation step numbers
did not accumulate. Interestingly, C30 desaturase CrtN showed
a higher apparent step number (four or five steps) in the C35
pathway than in its native C30 pathway (three or four steps).
Thus, cells with carotenoid biosynthetic enzymes CrtM and
CrtN develop intense red color in the presence of GGDP, due
to the production of highly desaturated C35 carotenoids (Fig.
2A).
Cyclization of C35 carotenoids. Most carotenoids in plants
and microorganisms are in cyclic forms, and various carotene
cyclases have been isolated. However, cyclization is known only
for C40 pathways. Several lycopene cyclases were reported to
convert the 7,8-dihydro 
 end along the C40 backbone in ad-
dition to their natural substrate, lycopene (
 end) (30). We
tested the function of two carotene cyclases, the -end cyclase
(CrtY) from E. uredovora and the ε-end cyclase from lettuce
(Dy4), in the C35 pathway.
When pUC-crtY was transformed into XL1 together with
pAC-crtM-crtN-crtE, two new carotenoids (compounds 11 and
12) (Fig. 4G) were observed in small amounts. Their charac-
teristic absorption spectra and molecular masses confirmed
that compounds 11 (M at m/e  468.4) and 12 (m/e  470.4)
are the monocyclic -end C35 carotenoids shown in Fig. 1.
Similarly, expression of pUC-dy4 with pAC-crtM-crtN-crtE re-
sulted in the production of two other carotenoids (compounds
13 and 14) (Fig. 4J). Absorption spectra and molecular masses
suggested that compounds 13 (m/e  468.2) and 14 (m/e 
470.4) are the monocyclic ε-end C35 carotenoids shown in Fig.
1.
Given the optical properties and molecular masses of the
respective carotenoids, there are two possible structures for
each of the four cyclic molecules 11 to 14 (structures a and b
in Fig. 1). Although we do not have conclusive evidence, we
believe that the cyclic carotenoids detected are of the a type
rather than the b type. The a-type carotenoids are synthesized
FIG. 4. HPLC profile of carotenoid extracts from XL1 cells carry-
ing plasmids pUC-crtM-crtN (A), pUC-crtM-crtN-crtE (B), pUC-crtM-
crtI-crtE (C), pAC-crtM-N6A-crtE (D), pAC-crtM-N10F-crtE (E),
pAC-crtM-I13-crtE (F), pUC-crtM-crtI-crtE and pUC-crtY (G), pAC-
crtM-crtN6A-crtE and pUC-crtY (H), pAC-crtM-crtI13-crtE and pUC-
crtY (I), pAC-crtM-crtN-crtE and pUC-dy4 (J), pAC-crtM-crtN6A-crtE
and pUC-dy4 (K), and pAC-crtM-crtI13-crtE and pUC-dy4 (L). Elution
conditions: 1 ml/min; acetonitrile–2-propanol (85:15). The detection
wavelength was 450 nm throughout the run, except for panel E, where
370 nm was used after 15 min. See Fig. 1 for putative structures for
each carotenoid. The spectrum of each C35 carotenoid (compounds 2
and 6 to 14) is given on the right.
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by cyclase action on the C20 half, whose 
 end is identical to
that of lycopene, the natural substrate of CrtY and Dy4, while
b-type pathways require cyclization on the shorter, unnatural
(C15) side. It has been noted that carotenoid-modifying en-
zymes in general recognize only a part of the substrate (4).
Modulating desaturase step number in the C35 pathway.
Both CrtN and CrtI are four- or five-step desaturases in the
C35 pathway and therefore accumulate acyclic C35 carotenoids
with either 11 (for compound 6) or 13 (for compound 7)
conjugated double bonds. To access C35 carotenoids with five,
seven, and nine conjugated double bonds, we used directed
evolution to alter the step numbers of these desaturases in the
pathway. Each desaturation step extends the chromophore by
two double bonds, providing a large bathochromic shift and a
basis for product-based color screening of desaturase variants
with altered step number. This approach has been used to alter
the step numbers of CrtI from Erwinia (27) and Rhodobacter
(34), as well as that of CrtN from Staphylococcus (D. Umeno,
unpublished data), in their respective natural pathways.
By using pUC-crtM-crtN-crtE as a template, a region cover-
ing the entire crtN reading frame was amplified by mutagenic
PCR. The PCR product was digested and ligated into the
desaturase site of pUC-crtM-crtN-crtE, resulting in the pUC-
crtM-[crtN]-crtE plasmid libraries. Similarly, pUC-crtM-[crtI]-
crtE libraries were created and screened for altered carotenoid
production. When XL1 cells were transformed with the pUC-
crtM-[crtN]-crtE libraries, we observed orange-red colonies
similar to those expressing the wild-type CrtN, as well as or-
ange, yellow, and virtually colorless colonies (Fig. 2B). About
100 yellow-to-white colonies were picked and inoculated in a
2-ml TB culture, and pigmentation was analyzed by the ab-
sorption spectrum of the pigment mixture extracted from each
variant sample. Because each cell produces a mixture of C30,
C40, and C35 carotenoids, color changes could occur in various
ways. In addition to an altered step number in the C35 pathway,
altered step numbers in other (C30 or C40) pathways, altered
specificity or preference for backbone size, and possibly a
change in the physical interaction with CrtM could generate
the different phenotypes. Thus, promising variants were har-
vested in a larger-scale culture (50 ml of TB), and pigment
composition was analyzed by HPLC.
From the variants analyzed, two CrtN variants (N6A and
N10F) and a CrtI variant (I13) were subcloned into the pACYC
vector. While XL1 carrying pAC-crtM-crtNwt-crtE accumulated
a mixture of five- and four-step products (Fig. 4B), XL1 having
pAC-crtM-N6A-crtE accumulated three-step product 8 (M
 at
m/e  470.4) as a major product (Fig. 4D). On the other hand,
transformation of XL1 with pUC-crtM-N10F-crtE resulted in
the accumulation of two-step (compound 9; m/e  472.4) and
one-step (compound 10; m/e  474.3) products (Fig. 4E).
Improving cyclic C35 carotenoid production. Both CrtY and
Dy4 converted C35 carotenoids in the presence of CrtM, CrtN,
and CrtE (Fig. 4G and 4J). However, the proportion of cyclic
C35 carotenoids accumulated was rather low. This could simply
mean that C35 carotenoids are not good substrates for C40
cyclases. Alternatively, it could be due to the suboptimal com-
bination of cyclase and desaturase enzymes. The pathways to
compounds 11 and 13 branch out from compound 7, while the
paths to compounds 12 and 14 start from compound 8. In
either case, the cyclization pathway must compete for substrate
with the desaturation pathway leading to compound 6. We
proposed that the level of cyclic C35 carotenoid could be en-
hanced by replacing wild-type CrtN with desaturase variants
with appropriate step numbers that accumulate, but do not
consume, the substrates for each planned pathway.
XL1 cells harboring pAC-crtM-N6A-crtE accumulated com-
pound 8 at high levels (Fig. 4D). When cyclases were coex-
pressed with this plasmid, compound 8 was efficiently con-
verted into compounds 12 (by CrtY) (Fig. 4H) and 14 (by Dy4)
(Fig. 4K). XL1 harboring pAC-crtM-I13-crtE accumulates a
high level of compound 7 (Fig. 4F), the direct precursor for
compounds 11 and 13. Upon expression of cyclases CrtY and
Dy4, compounds 11 (by CrtY) (Fig. 4I) and 13 (by Dy4) (Fig.
4L) were produced at high proportions. Thus, modulation of
the precursor supply was sufficient to selectively produce each
of four cyclic carotenoids. This context-dependent switching of
the cyclization products demonstrates how readily these en-
zymes accept new substrates.
DISCUSSION
The C35 pathway and evolution of the carotenoid pathways.
Many carotenoid-producing enzymes are promiscuous, accept-
ing a range of substrates (9, 10, 21, 30). Carotene desaturases
from C30 and C40 pathways can complement each other (21,
33). Nevertheless, C40 carotenoids have not been isolated from
C30 carotenoid-synthesizing organisms (32), and C30 carote-
noids are not seen in C40 organisms. This complete isolation of
natural C30 and C40 carotenoid pathways occurs even though
they are very similar, except in the size of their precursor
molecules. Carotene synthases are the likely source of this
specificity. It was shown that, unlike carotene desaturases, nei-
ther the C30 nor the C40 carotene synthase was functional in
the other pathway (21, 33). Indeed, Erwinia CrtB produced C40
carotenoid only, with not even a trace amount of C35 or a
smaller carotenoid, when expressed in E. coli also expressing
CrtE, despite the availability of both GGDP and FDP (Fig.
3C). In the absence of GGDP, CrtB produced no carotenoids
at all.
In this work, we have shown that Staphylococcus CrtM, a
synthase from a C30 pathway, synthesizes C35 carotenoids in
the presence of GGDP. CrtM can condense two FDP mole-
cules; it can also accept one (or two) molecules of GGDP in
the same reaction. In the absence of CrtE, however, CrtM
produces C30 carotenoids (4,4-diapophytoene) exclusively
(Fig. 3B). Thus, specificity of the C30 pathway against the
production of larger carotenoids is achieved by limiting the
precursor pool (environment) and not by the synthase itself.
Asymmetry of carotenoid structures ensures greater molec-
ular diversity in the C35 pathway. Because C35 carotenoids
have asymmetrical backbone structures, each desaturation step
along the backbone yields more than one product. Thus, acy-
clic C35 carotenoids with 3, 5, 7, 9, 11, and 13 conjugated
double bonds can take 1, 2, 3, 3, 2, and 1 (total of 12) possible
structures, respectively (Fig. 1), while C40 has 9 possible struc-
tures for 6 different chromophore sizes. Cyclization and other
modifications of the backbone can further increase the number
of possible C35 carotenoids compared to symmetrical (natural)
carotenoids. Thus, the C35 pathway is inherently more complex
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and explores a much larger “structure space” than the sym-
metrical C30 and C40 pathways.
Many enzymes in carotenoid pathways have been reported
to have broad substrate specificity (9–11, 19, 21, 30), including
the ability to act on carotenoids of different backbone size (21,
33). Many carotenoid-modifying enzymes are expected to be
functional in the C35 pathway, as were the four enzymes tested
in this work (CrtN, CrtI, CrtY, and Dy4). We predict that the
C35 carotenoid pathway products can be metabolized by addi-
tional C40 or C30 enzymes, which will further expand the di-
versity of novel carotenoids that can be generated.
Matching of components enhances the discovery of novel
chemicals. Due to their promiscuity, secondary metabolic en-
zymes can be expressed combinatorially to produce, in theory,
a very large number of chemical structures. Garcia-Asua et al.
observed the accumulation of a series of uncommon carote-
noids in Rhodobacter sphaeroides when they replaced its natu-
ral three-step desaturase with a four-step counterpart from
Erwinia (9, 10). Here we have demonstrated that addition of a
single enzyme, GGDP synthase, creates a whole new pathway
to C35 carotenoids.
Most of the chemicals from this potentially rich source,
however, are not accessible by simple assembly of natural bio-
synthetic enzymes. Often, this approach merely results in the
production of unwanted compounds. For example, attempts to
construct a pathway for astaxanthin production by expressing
all of the required enzymes in a host organism resulted in
astaxanthin formation as only a minor component of a complex
mixture (11, 19). In another example, introduction of carot-
enoid biosynthetic enzymes from Erwinia (CrtB, CrtI, CrtY,
and CrtZ) into a mutant of Rhodobacter with the desaturase
deleted only restored the desaturation activity and failed to
alter the organism’s carotenoid product range (13). In that
case, the endogenous hydroxylation activity on neurosporene
was so high that the activities introduced from Erwinia failed to
compete for this intermediate. The additional knockout of
neurosporene hydroxylase CrtC was necessary to make the
pathway functional (10). Such miscoordination of pathway
components (enzymes) is a major barrier for pathway engi-
neers who hope to freely explore the biosynthetic diversity
made possible by the given transformations. This is especially
true for pathways constructed from highly promiscuous en-
zymes. In this work, when cyclases were expressed with wild-
type CrtN, very low levels of cyclic C35 carotenoids (com-
pounds 11 to 14) were produced. However, tuning the step
number of the desaturase by directed evolution enabled us to
generate cells that produce each of these four carotenoids as
the major product. Thus, altering the working environment of
secondary metabolic enzymes can result in the emergence of
novel pathways (8). Here, the major task of pathway engineers
is to tune the coordination of the assembled components in
order to unmask hidden pathways awaiting discovery. We pro-
pose that this tuning can be conducted systematically by di-
rected evolution, a powerful optimization strategy that is ap-
plicable to many different systems, all in the absence of
detailed information on individual components (36).
The C35 pathway provides a unique opportunity to study the
nature of carotenoid biosynthetic pathways. In this paper, we
have described a route to novel C35 carotenoids. This can be
regarded as a consequence of uptake of a larger substrate
(GGDP) by the C30 carotene synthase CrtM. Once formed,
however, this “artifact” pathway recruited various downstream
enzymes, and thus a full-fledged C35 carotenoid pathway was
established. We believe what we have observed is a model of
how nature can access a variety of new metabolites in a short
period of time.
An important question is whether this newly born pathway
can become a mature, specific one (i.e., making only C35 caro-
tenoids). We recently demonstrated that the substrate and
product specificities of a carotene synthase can be altered by a
single amino acid substitution (33). However, unlike C30 or C40
synthase, a C35-specific synthase must favor the condensation
of two nonidentical substrate molecules. Can we breed a C35
synthase that conducts this particular reaction, regardless of
the cellular levels of FDP and GGDP? Can we force CrtM to
become selective against larger prenyldiphosphates, so that it
would produce only C30 carotenoids, even in the presence of a
high level of GGDP? Such questions can be addressed by
further laboratory evolution of carotene synthases.
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